Markel Group Inc. (MKL)

Executive Summary

Markel Group is three businesses stapled together: a specialty insurer that wrote $12.5 billion of gross premium in 2025 and earned a 14% return on its own equity, a $13.5 billion portfolio of public equities carrying $9.3 billion of unrealized gains against a $4.2 billion cost basis, and a group of wholly-owned industrial, financial and consumer businesses that produced $845 million of adjusted operating income last year. At $1,818.69 the market pays 1.19 times book value for all of it, against a thirteen-year median of 1.43x — and it pays that in a period when the underwriting engine has visibly improved, with the combined ratio at 93% for both the second quarter and the first half of 2026 against 97% and 96% a year earlier. This report works through what that discount is actually made of: the fifteen-year book value record, why GAAP earnings are the wrong lens for an insurer that marks a $13.5 billion equity book through income, the newly disaggregated segment economics, the $205.3 million State National credit provision, a same-date peer comparison against Chubb, W. R. Berkley, RLI, American Financial and Fairfax, the balance sheet and its $15.8 billion of reinsurance recoverables, the unresolved JANA Partners campaign and the board’s business review, the insider record, and the risks an investor has to weigh before deciding whether the conglomerate discount is a mispricing or a verdict.

What’s Inside The Full Report

• 15-year financial summary table — revenue, net income, GAAP & adjusted EPS
• Valuation framework — current multiples vs. 5-year historical range
• Peer comparison table — multiples, margins, balance-sheet metrics
• Base case, bull case, bear case price targets with explicit math
• Competitive position and economic moat analysis
• Management and capital allocation track record
• Balance sheet review — leverage, credit ratings, distribution coverage
• Insider activity — recent open-market buys / sells with interpretation
• Strategic acquisitions and divestitures history
• Sell-side consensus and where TTCM differs
• Detailed risk factors specific to the name
• Bull case and forward catalysts to watch
• TTCM’s overall rating and the specific price levels that would change our view